Your browser doesn't support javascript.
loading
Clinical and technical outcomes of robotic versus manual percutaneous coronary intervention: A systematic review and meta-analysis.
Jaffar-Karballai, Mona; Haque, Aniqa; Voller, Calum; Elleithy, Assem; Harky, Amer.
Afiliação
  • Jaffar-Karballai M; Department of Medicine, St George's University of London, London, UK.
  • Haque A; Department of Medicine, St George's University of London, London, UK.
  • Voller C; School of Medicine, University of Liverpool, Liverpool, UK.
  • Elleithy A; UCLan Medical School, University of Central Lancashire, Preston, UK.
  • Harky A; Department of Cardiothoracic Surgery, Liverpool Heart and Chest Hospital, Liverpool, UK; Liverpool Centre for Cardiovascular Science, University of Liverpool, Liverpool Heart and Chest Hospital, Liverpool, UK. Electronic address: aaharky@gmail.com.
J Cardiol ; 80(6): 495-504, 2022 12.
Article em En | MEDLINE | ID: mdl-35165012
ABSTRACT

BACKGROUND:

Robotic percutaneous coronary intervention (R-PCI) is a promising medical procedure being used in clinical settings, which is thought to produce superior clinical and technical outcomes compared to the traditional manual approach. We performed a systematic review and meta-analysis to compare R-PCI to manual PCI (M-PCI).

METHODS:

A systematic literature search was performed using Pubmed, Medline (Ovid), Google Scholar, SCOPUS, and Embase from inception until the end of August 2021. Keywords used were ''Robotic PCI'' and ''Robotic angioplasty.'' Twenty studies were included for the qualitative analysis and seven for the pooled meta-analyses.

RESULTS:

There was no significant difference between R-PCI and M-PCI groups in terms of clinical success (risk ratio 1.01, 95% CI 0.99-1.02, p=0.45) and procedure time (mean difference 4.55, 95% CI 0.08-9.02, p=0.05). Both contrast volume (mean difference -15.27, 95% CI -22.37 - -8.18, p<0.0001) and fluoroscopy time (mean difference -1.26, 95% CI -2.37 - -0.16, p=0.03) were significantly lower in the R-PCI group. Technical success rates in all studies were equal to or greater than 70% (mean 93.1, SD 7.8), with four studies reporting 100% success rates.

CONCLUSION:

Given the comparable clinical short-term safety of R-PCI to that of M-PCI and the high technical success rates across several large, high-quality cohort studies, the clinician can be reassured about the ability of robotic devices. However, randomized long-term data are warranted before making prospective conclusions on the clinical and technical merits of R-PCI and adopting it as part of standard coronary interventions.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença da Artéria Coronariana / Intervenção Coronária Percutânea / Procedimentos Cirúrgicos Robóticos Tipo de estudo: Clinical_trials / Guideline / Observational_studies / Qualitative_research / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença da Artéria Coronariana / Intervenção Coronária Percutânea / Procedimentos Cirúrgicos Robóticos Tipo de estudo: Clinical_trials / Guideline / Observational_studies / Qualitative_research / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article